|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,389.40 INR | +0.44% |
|
-0.85% | -8.07% |
| 06-12 | India raises price cap on cancer drugs to tackle shortage | RE |
| 06-11 | Cipla's Goa, India Facility Receives VAI Status from US FDA | MT |
Company Valuation: Cipla Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 821,377 | 726,839 | 1,208,588 | 1,164,745 | 988,887 | 1,122,358 | - | - |
| Change | - | -11.51% | 66.28% | -3.63% | -15.1% | 13.5% | - | - |
| Enterprise Value (EV) 1 | 810,334 | 716,397 | 1,154,239 | 1,084,736 | 901,599 | 1,023,708 | 997,488 | 980,417 |
| Change | - | -11.59% | 61.12% | -6.02% | -16.88% | 13.54% | -2.56% | -1.71% |
| P/E Ratio | 32.7x | 26x | 29.3x | 22.1x | 25.5x | 26.8x | 21.9x | 19.4x |
| PBR | 3.94x | 3.11x | 4.53x | 3.73x | 2.87x | 2.98x | 2.7x | 2.45x |
| PEG | - | 2.3x | 0.6x | 0.8x | -1x | 3.38x | 1x | 1.5x |
| Capitalization / Revenue | 3.77x | 3.19x | 4.69x | 4.23x | 3.51x | 3.61x | 3.24x | 2.96x |
| EV / Revenue | 3.72x | 3.15x | 4.48x | 3.94x | 3.2x | 3.3x | 2.88x | 2.59x |
| EV / EBITDA | 17.8x | 14.3x | 18.3x | 15.2x | 15.3x | 16.9x | 13.6x | 11.9x |
| EV / EBIT | 23.1x | 18.6x | 22x | 18x | 19.3x | 21.5x | 16.7x | 14.4x |
| EV / FCF | 29.1x | 29.9x | 38x | 28.2x | 38.5x | 34x | 27.6x | 26x |
| FCF Yield | 3.43% | 3.35% | 2.63% | 3.54% | 2.6% | 2.94% | 3.62% | 3.85% |
| Dividend per Share 2 | 5 | 8.5 | 13 | 13 | 13 | 12.47 | 14.15 | 14.1 |
| Rate of return | 0.49% | 0.94% | 0.87% | 0.9% | 1.06% | 0.9% | 1.02% | 1.01% |
| EPS 2 | 31.17 | 34.69 | 51.01 | 65.24 | 48 | 51.81 | 63.39 | 71.67 |
| Distribution rate | 16% | 24.5% | 25.5% | 19.9% | 27.1% | 24.1% | 22.3% | 19.7% |
| Net sales 1 | 217,633 | 227,531 | 257,741 | 275,476 | 281,626 | 310,614 | 346,427 | 378,943 |
| EBITDA 1 | 45,528 | 50,270 | 62,910 | 71,279 | 58,829 | 60,649 | 73,604 | 82,700 |
| EBIT 1 | 35,008 | 38,549 | 52,400 | 60,210 | 46,719 | 47,621 | 59,650 | 67,909 |
| Net income 1 | 25,168 | 28,019 | 41,216 | 52,725 | 38,792 | 41,871 | 51,212 | 57,759 |
| Net Debt 1 | -11,043 | -10,443 | -54,350 | -80,010 | -87,289 | -98,650 | -124,870 | -141,941 |
| Reference price 2 | 1,018.05 | 900.50 | 1,496.95 | 1,442.20 | 1,224.20 | 1,389.40 | 1,389.40 | 1,389.40 |
| Nbr of stocks (in thousands) | 806,814 | 807,151 | 807,367 | 807,617 | 807,783 | 807,801 | - | - |
| Announcement Date | 10/05/22 | 12/05/23 | 10/05/24 | 13/05/25 | 13/05/26 | - | - | - |
1INR in Million2INR
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 26.82x | 3.3x | 16.88x | 0.9% | 11.81B | |
| 37.29x | 7.06x | 24.07x | 0.83% | 45.63B | |
| 17.01x | 1.89x | 8.98x | 1.43% | 33.53B | |
| 24.23x | 4.23x | 15.75x | 0.73% | 11.69B | |
| 19.49x | 3.37x | 12.21x | 3.5% | 9.12B | |
| 8.33x | 1.96x | 5.12x | 5.2% | 7.16B | |
| 14.59x | 1.91x | 7.25x | 3.68% | 6.49B | |
| 33x | 3.75x | 15.96x | 0.24% | 6.45B | |
| 41.73x | - | - | - | 5.16B | |
| 37.34x | 7.14x | 26.48x | 1.06% | 4.11B | |
| Average | 25.98x | 3.85x | 14.74x | 1.95% | 14.12B | |
| Weighted average by Cap. | 26.82x | 4.30x | 16.10x | 1.5% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CIPLA Stock
- Valuation Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
